129 related articles for article (PubMed ID: 32484691)
1. Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An
Canonico B; Carloni R; Sanz Del Olmo N; Papa S; Nasoni MG; Fattori A; Cangiotti M; de la Mata FJ; Ottaviani MF; García-Gallego S
Mol Pharm; 2020 Jul; 17(7):2691-2702. PubMed ID: 32484691
[TBL] [Abstract][Full Text] [Related]
2. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models.
Sanz Del Olmo N; Carloni R; Bajo AM; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
Nanoscale; 2019 Jul; 11(28):13330-13342. PubMed ID: 31271405
[TBL] [Abstract][Full Text] [Related]
3. Elaborated study of Cu(II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents.
Carloni R; Sanz Del Olmo N; Canonico B; Montanari M; Ciacci C; Ambrosi G; de la Mata FJ; Ottaviani MF; García-Gallego S
Eur J Med Chem; 2021 Apr; 215():113292. PubMed ID: 33631696
[TBL] [Abstract][Full Text] [Related]
4. Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.
Sanz Del Olmo N; Maroto-Díaz M; Gómez R; Ortega P; Cangiotti M; Ottaviani MF; de la Mata FJ
J Inorg Biochem; 2017 Dec; 177():211-218. PubMed ID: 29031179
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a fluorescent 1,8-naphthalimide-functionalized PAMAM dendrimer and its Cu(ii) complexes as cytotoxic drugs: EPR and biological studies in myeloid tumor cells.
Canonico B; Cangiotti M; Montanari M; Papa S; Fusi V; Giorgi L; Ciacci C; Ottaviani MF; Staneva D; Grabchev I
Biol Chem; 2022 Feb; 403(3):345-360. PubMed ID: 34883001
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR.
Carloni R; Sanz Del Olmo N; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569790
[TBL] [Abstract][Full Text] [Related]
7. Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.
Galan M; Sanchez-Rodriguez J; Cangiotti M; Garcia-Gallego S; Jimenez JL; Gomez R; Ottaviani MF; Munoz-Fernandez MA; de la Mata FJ
Curr Med Chem; 2012; 19(29):4984-94. PubMed ID: 22963631
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Anticancer Properties of Copper Metallodendrimers.
Hołota M; Magiera J; Michlewska S; Kubczak M; Del Olmo NS; García-Gallego S; Ortega P; de la Mata FJ; Ionov M; Bryszewska M
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31003561
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Effect of Carbosilane Metallodendrimers in Planktonic Cells of Gram-Positive and Gram-Negative Bacteria and
Llamazares C; Sanz Del Olmo N; Ortega P; Gómez R; Soliveri J; de la Mata FJ; García-Gallego S; Copa-Patiño JL
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450779
[TBL] [Abstract][Full Text] [Related]
10. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models.
Hołota M; Michlewska S; Garcia-Gallego S; Del Olmo NS; Ortega P; Bryszewska M; de la Mata FJ; Ionov M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835489
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium dendrimers as carriers for anticancer siRNA.
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Loznikova S; Shcharbin D; Maly M; Ramirez RG; de la Mata FJ; Bryszewska M
J Inorg Biochem; 2018 Apr; 181():18-27. PubMed ID: 29353086
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.
Michlewska S; Kubczak M; Maroto-Díaz M; Sanz Del Olmo N; Ortega P; Shcharbin D; Gomez Ramirez R; Javier de la Mata F; Ionov M; Bryszewska M
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450702
[TBL] [Abstract][Full Text] [Related]
13. Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells.
Pedziwiatr-Werbicka E; Fuentes E; Dzmitruk V; Sánchez-Nieves J; Sudas M; Drozd E; Shakhbazau A; Shcharbin D; de la Mata FJ; Gomez-Ramirez R; Munoz-Fernandez MA; Bryszewska M
Colloids Surf B Biointerfaces; 2013 Sep; 109():183-9. PubMed ID: 23643914
[TBL] [Abstract][Full Text] [Related]
14. Copper(II) binding to flexible triethanolamine-core PAMAM dendrimers: a combined experimental/in silico approach.
Ottaviani MF; Cangiotti M; Fattori A; Coppola C; Posocco P; Laurini E; Liu X; Liu C; Fermeglia M; Peng L; Pricl S
Phys Chem Chem Phys; 2014 Jan; 16(2):685-94. PubMed ID: 24256926
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications.
Bermejo JF; Ortega P; Chonco L; Eritja R; Samaniego R; Müllner M; de Jesus E; de la Mata FJ; Flores JC; Gomez R; Muñoz-Fernandez A
Chemistry; 2007; 13(2):483-95. PubMed ID: 17004291
[TBL] [Abstract][Full Text] [Related]
16. Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells.
Sanz Del Olmo N; Holota M; Michlewska S; Gómez R; Ortega P; Ionov M; de la Mata FJ; Bryszewska M
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32748821
[TBL] [Abstract][Full Text] [Related]
17. Magnetic properties of poly(propylene imine)-copper dendromesogenic complexes: An EPR study.
Domracheva N; Mirea A; Schwoerer M; Torre-Lorente L; Lattermann G
Chemphyschem; 2006 Dec; 7(12):2567-77. PubMed ID: 17089431
[TBL] [Abstract][Full Text] [Related]
18. Insight on the Structure-to-Activity of Carbosilane Metallodendrimers in the Fight against
Llamazares C; Sanz Del Olmo N; Soliveri J; de la Mata FJ; Copa-Patiño JL; García-Gallego S
Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34067558
[TBL] [Abstract][Full Text] [Related]
19. New anionic carbosilane dendrons functionalized with a DO3A ligand at the focal point for the prevention of HIV-1 infection.
Moreno S; Sepúlveda-Crespo D; de la Mata FJ; Gómez R; Muñoz-Fernández MÁ
Antiviral Res; 2017 Oct; 146():54-64. PubMed ID: 28827122
[TBL] [Abstract][Full Text] [Related]
20. Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration.
Bravo-Osuna I; Vicario-de-la-Torre M; Andrés-Guerrero V; Sánchez-Nieves J; Guzmán-Navarro M; de la Mata FJ; Gómez R; de Las Heras B; Argüeso P; Ponchel G; Herrero-Vanrell R; Molina-Martínez IT
Mol Pharm; 2016 Sep; 13(9):2966-76. PubMed ID: 27149661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
